Mallon Mark

Track

Insider profile

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mallon Mark's trades of Neogenomics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
332.59
Quantity 33,531 +1.0%
Value US$4,804,619
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-06 2021-12-06
B Purchase
33,531 +1.0%
332.59
US$4,804,619 		33,531 +1.0% 332.59 US$4,804,619
2021-03-02 2021-02-26
PlS Planned sale
77,896 -5.5%
460.53
US$2,083,385 		77,896 -5.5% 460.53 US$2,083,385
2021-03-02 2021-02-26
PlS Planned sale
21,438 +22.4%
249.84
US$4,321,200 		21,438 +22.4% 249.84 US$4,321,200
2020-05-13 2020-05-11
PlS Planned sale
23,206 -4.4%
10.35
US$240,182 		23,206 -4.4% 10.35 US$240,182
2020-02-25 2020-02-24
PlS Planned sale
1 -0.0%
11.25
US$11 		1 -0.0% 11.25 US$11
2020-02-25 2020-02-21
PlS Planned sale
7,983 -2.6%
11.63
US$92,842 		7,983 -2.6% 11.63 US$92,842